Archive - April 2025
FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin
Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection
New study reveals how tumors hijack key nutrient to evade immune attack
U.S. FDA Grants Full Approval of Vitrakvi (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive Solid Tumors
FDA Approves an Updated Label for Tryvio (aprocitentan) Removing the REMS Requirement
Alternative approach to Lyme disease vaccine development shows promise in pre-clinical models
Researchers find key to treating painful dry mouth disorder
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer